Caliway Advances Fat-Reducing Drug with Global Study

Caliway Biopharmaceuticals just got the green light from the FDA to kick off a major Phase 3 study for their new fat-reducing drug, CBL-514. This study will be happening across multiple countries and aims to prove the drug is safe and effective by 2027. Meanwhile, they're also expanding studies in Asia to ensure the drug works well for different demographics. What does it mean for you? If you're dreaming of a future with fuss-free fat reduction, Caliway's hustle might just make it a reality, bringing us one step closer to a new way to tackle stubborn fat without surgery.